dimethyl fumarate

trans- butene dioic acid dimethyl ester 2- butenedioic acid (E)-, dimethyl ester dimethyl (E)-but-2-enedioate dimethyl trans-butene dioate dimethylfumarate fumaric acid dimethyl ester fumaric acid, dimethyl ester PubMed: Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. PubMed: Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients. PubMed: Update on disease-modifying therapies for multiple sclerosis. PubMed: (1) H qNMR Quantification of Annonaceous Acetogenins in Crude Extracts of Annona muricata L. Fruit Pulp. PubMed: Liver injury associated with dimethyl fumarate in multiple sclerosis patients. PubMed: Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis. PubMed: Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats. PubMed: Teriflunomide for multiple sclerosis. PubMed: Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes. PubMed: Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE). PubMed: Currently approved and emerging oral therapies in multiple sclerosis: An update for the ophthalmologist. PubMed: Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study. PubMed: Novel Agents for Relapsing Forms of Multiple Sclerosis. PubMed: Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis. PubMed: [Determination of dimethyl fumarate in bakery food by d-SPE-HPLC-PDA]. PubMed: Dimethyl fumarate for multiple sclerosis. PubMed: Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel. PubMed: New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis. PubMed: Oral disease-modifying therapies for relapsing-remitting multiple sclerosis. PubMed: Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP. PubMed: Multiple sclerosis: a primary care perspective. PubMed: Dimethyl fumarate protection against collagen II degradation. PubMed: Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate. PubMed: Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis. PubMed: Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways. PubMed: An update on new and emerging therapies for relapsing-remitting multiple sclerosis. PubMed: Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. PubMed: Risk assessment of dimethylfumarate residues in dwellings following contamination by treated furniture. PubMed: Multiple sclerosis: Five new things. PubMed: The top 10 drug trends right now. PubMed: Drugs: An injection of hope. PubMed: Globalisation and allergy. PubMed: Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis. PubMed: Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis. PubMed: [Effects of chemical agents on the prevention of fungal contamination during household wheat storage in Cixian county]. PubMed: Inhibition of Escherichia coli by dimethyl fumarate. PubMed: Elevation of serum phase II enzymes by anticarcinogenic enzyme inducers: markers for a chemoprotected state? PubMed: Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues.